M3 (2413) Stock Overview
Provides medical-related services primarily to physicians and other healthcare professionals through the Internet. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 3/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
2413 Community Fair Values
See what others think this stock is worth. Follow their fair value or set your own to get alerts.
M3, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥2,326.00 |
52 Week High | JP¥2,433.00 |
52 Week Low | JP¥1,248.00 |
Beta | 0.92 |
1 Month Change | 3.29% |
3 Month Change | 14.78% |
1 Year Change | 60.08% |
3 Year Change | -42.61% |
5 Year Change | -63.99% |
Change since IPO | 2,399.58% |
Recent News & Updates
Recent updates
M3, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 11M3 (TSE:2413) Seems To Use Debt Quite Sensibly
Jul 28Calculating The Intrinsic Value Of M3, Inc. (TSE:2413)
Jul 15Is It Time To Consider Buying M3, Inc. (TSE:2413)?
Jun 17Here's What's Concerning About M3's (TSE:2413) Returns On Capital
May 17M3 (TSE:2413) Has A Pretty Healthy Balance Sheet
Mar 22M3's (TSE:2413) Upcoming Dividend Will Be Larger Than Last Year's
Mar 06Earnings Tell The Story For M3, Inc. (TSE:2413) As Its Stock Soars 41%
Feb 20M3, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 12Investors Could Be Concerned With M3's (TSE:2413) Returns On Capital
Feb 06Estimating The Intrinsic Value Of M3, Inc. (TSE:2413)
Jan 22With M3, Inc. (TSE:2413) It Looks Like You'll Get What You Pay For
Jan 06We Think M3 (TSE:2413) Can Stay On Top Of Its Debt
Dec 19Earnings Miss: M3, Inc. Missed EPS By 36% And Analysts Are Revising Their Forecasts
Nov 01Is M3, Inc. (TSE:2413) Potentially Undervalued?
Oct 21M3, Inc. (TSE:2413) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected
Oct 06Return Trends At M3 (TSE:2413) Aren't Appealing
Sep 23Shareholder Returns
2413 | JP Healthcare Services | JP Market | |
---|---|---|---|
7D | -1.9% | -0.3% | -0.4% |
1Y | 60.1% | 36.7% | 18.5% |
Return vs Industry: 2413 exceeded the JP Healthcare Services industry which returned 36.7% over the past year.
Return vs Market: 2413 exceeded the JP Market which returned 18.5% over the past year.
Price Volatility
2413 volatility | |
---|---|
2413 Average Weekly Movement | 7.5% |
Healthcare Services Industry Average Movement | 5.4% |
Market Average Movement | 3.3% |
10% most volatile stocks in JP Market | 7.5% |
10% least volatile stocks in JP Market | 1.7% |
Stable Share Price: 2413's share price has been volatile over the past 3 months compared to the JP market.
Volatility Over Time: 2413's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2000 | 15,360 | Itaru Tanimura | corporate.m3.com |
M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through the Internet. The company operates through five reporting segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, and Overseas. It operates m3.com, a members-only website for providing information to healthcare professionals; MR-kun, where member doctors can independently and continuously receive information on the m3com platform; AskDoctors, where registered doctors answer questions about health and illness from the public; MDLinx for medical professionals in the United States; and Doctors.net.uk, a website that provides developing services for pharmaceutical companies, as well as provides drug information database in France, Germany, and Spain.
M3, Inc. Fundamentals Summary
2413 fundamental statistics | |
---|---|
Market cap | JP¥1.57t |
Earnings (TTM) | JP¥41.27b |
Revenue (TTM) | JP¥306.89b |
Is 2413 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2413 income statement (TTM) | |
---|---|
Revenue | JP¥306.89b |
Cost of Revenue | JP¥130.54b |
Gross Profit | JP¥176.36b |
Other Expenses | JP¥135.09b |
Earnings | JP¥41.27b |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Nov 12, 2025
Earnings per share (EPS) | 60.88 |
Gross Margin | 57.47% |
Net Profit Margin | 13.45% |
Debt/Equity Ratio | 5.9% |
How did 2413 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/09/22 14:30 |
End of Day Share Price | 2025/09/22 00:00 |
Earnings | 2025/06/30 |
Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
M3, Inc. is covered by 24 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Ritsuo Watanabe | BofA Global Research |
Aaron Ho | CFRA Equity Research |
Luoxin Jiang | Citic Securities Co., Ltd. |